Product References
Location-specific inhibition of Akt reveals regulation of mTORC1 activity in the nucleus.
Nature communications
Zhou X,Zhong Y,Molinar-Inglis O,Kunkel MT,Chen M,Sun T,Zhang J,Shyy JY,Trejo J,Newton AC,Zhang J
AHO1031 was used in Immunocytochemistry-immunoflourescence to reveal a mode of regulation of mTORC1 that is distinct from its lysosomal activation, which controls mTORC1 activity in the nuclear compartment.
Mon Nov 30 00:00:00 EST 2020
Combination of heat shock protein 90 and focal adhesion kinase inhibitors synergistically inhibits the growth of non-small cell lung cancer cells.
Oncoscience
Webber PJ,Park C,Qui M,Ramalingam SS,Khuri FR,Fu H,Du Y
Published figure using PRAS40 monoclonal antibody (Product # AHO1031) in Western Blot
Tue Oct 27 00:00:00 EDT 2015
Characterization of the activity of the PI3K/mTOR inhibitor XL765 (SAR245409) in tumor models with diverse genetic alterations affecting the PI3K pathway.
Molecular cancer therapeutics
Yu P,Laird AD,Du X,Wu J,Won KA,Yamaguchi K,Hsu PP,Qian F,Jaeger CT,Zhang W,Buhr CA,Shen P,Abulafia W,Chen J,Young J,Plonowski A,Yakes FM,Chu F,Lee M,Bentzien F,Lam ST,Dale S,Matthews DJ,Lamb P,Foster P
AHO1031 was used in western blot to study the anti-tumor effects of a pan class I PI3 kinase/mTOR inhibitor in cells with a genetically diverse range of PI3 kinase pathway modifications.
Thu May 01 00:00:00 EDT 2014
Effects of adding exercise to a 16-week very low-calorie diet in obese, insulin-dependent type 2 diabetes mellitus patients.
The Journal of clinical endocrinology and metabolism
Snel M,Gastaldelli A,Ouwens DM,Hesselink MK,Schaart G,Buzzigoli E,Frölich M,Romijn JA,Pijl H,Meinders AE,Jazet IM
Sun Jul 01 00:00:00 EDT 2012
Phosphorylation of PRAS40 on Thr246 by PKB/AKT facilitates efficient phosphorylation of Ser183 by mTORC1.
Cellular signalling
Nascimento EB,Snel M,Guigas B,van der Zon GC,Kriek J,Maassen JA,Jazet IM,Diamant M,Ouwens DM
Tue Jun 01 00:00:00 EDT 2010
Phosphorylation of PRAS40 on Thr246 by PKB/AKT facilitates efficient phosphorylation of Ser183 by mTORC1.
Cellular signalling
Nascimento EB,Snel M,Guigas B,van der Zon GC,Kriek J,Maassen JA,Jazet IM,Diamant M,Ouwens DM
Tue Jun 01 00:00:00 EDT 2010
Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40.
Nature cell biology
Vander Haar E,Lee SI,Bandhakavi S,Griffin TJ,Kim DH
Thu Mar 01 00:00:00 EST 2007
Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40.
Nature cell biology
Vander Haar E,Lee SI,Bandhakavi S,Griffin TJ,Kim DH
Thu Mar 01 00:00:00 EST 2007
Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40.
Nature cell biology
Vander Haar E,Lee SI,Bandhakavi S,Griffin TJ,Kim DH
Thu Mar 01 00:00:00 EST 2007
Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40.
Nature cell biology
Vander Haar E,Lee SI,Bandhakavi S,Griffin TJ,Kim DH
Thu Mar 01 00:00:00 EST 2007
The proline-rich Akt substrate of 40 kDa (PRAS40) is a physiological substrate of mammalian target of rapamycin complex 1.
The Journal of biological chemistry
Oshiro N,Takahashi R,Yoshino K,Tanimura K,Nakashima A,Eguchi S,Miyamoto T,Hara K,Takehana K,Avruch J,Kikkawa U,Yonezawa K
AHO1031 was used in western blot to show that proline-rich Akt substrate of 40 kilodaltons is a raptor-binding protein phosphorylated directly by mammalian target of rapamycin complex 1
Fri Jul 13 00:00:00 EDT 2007